Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants

NCT: NCT04703738 · COMPLETED

NCT IDNCT04703738
StatusCOMPLETED
Start Date2018-08-13
Completion2026-05-12
SponsorGeistlich Pharma AG (INDUSTRY)
First posted
Last updated

Brief Summary

This double blind, randomized, parallel study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for soft tissue volume augmentation around dental implants

Frequently Asked Questions

What is Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants?

Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants is a clinical trial registered under NCT04703738. Current status: COMPLETED.

What is the status of NCT04703738?

The current status of NCT04703738 (Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants) is: COMPLETED.

When did Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants start?

Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants started on 2018-08-13.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.